Ralf Kuriyel Repligen Corp (RGEN) insider trading activity

Ralf Kuriyel is Senior VP, R&D of REPLIGEN CORP. Currently has a direct ownership of 16,062 shares of RGEN, which is worth approximately $2.39 Million. The most recent transaction as insider was on Feb 28, 2022, when has been sold 4,234 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.1K

0% 3M change

30.71% 12M change

Total Value Held $2.39 Million

RALF KURIYEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2022	BUY Grant, award, or other acquisition	-	4,234 Added 15.89%	22,406 Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$93,826 $196.7 p/Share	477 Reduced 2.49%	18,645 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$35,571 $189.21 p/Share	188 Reduced 0.97%	19,122 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	2,126 Added 9.92%	19,310 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$31,923 $182.42 p/Share	175 Reduced 1.01%	17,184 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	450 Added 2.53%	17,359 Common Stock
Dec 14 2021	SELL Payment of exercise price or tax liability	$112,376 $252.53 p/Share	445 Reduced 2.56%	16,909 Common Stock
Aug 30 2021	SELL Open market or private sale	$1,128,802 $282.13 p/Share	4,001 Reduced 18.74%	17,354 Common Stock
Jun 10 2021	SELL Open market or private sale	$1,286,870 $189.19 p/Share	6,802 Reduced 24.16%	21,355 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$262,262 $72.81 p/Share	3,602 Added 11.34%	28,157 Common Stock
May 14 2021	SELL Open market or private sale	$122,326 $172.29 p/Share	710 Reduced 2.81%	24,555 Common Stock
Mar 10 2021	SELL Open market or private sale	$1,529,440 $191.18 p/Share	8,000 Reduced 24.05%	25,265 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$337,200 $42.15 p/Share	8,000 Added 19.39%	33,265 Common Stock
Mar 04 2021	SELL Open market or private sale	$400,081 $192.81 p/Share	2,075 Reduced 7.59%	25,265 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	1,686 Added 5.81%	27,340 Common Stock
Dec 16 2020	SELL Open market or private sale	$80,988 $186.18 p/Share	435 Reduced 1.67%	25,654 Common Stock

Ralf Kuriyel

Senior VP, R&D

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account